Pharmaceuticals · Key players

Top HIV Drugs companies

The 8 key players our HIV Drugs report profiles, and other companies free public records show in this market.

Key players in HIV Drugs

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the HIV Drugs market
#CompanyWebsiteOur reports
1 Gilead Sciences, Inc. gilead.com (opens in a new tab) 297 reports
2 ViiV Healthcare viivhealthcare.com (opens in a new tab) 66 reports
3 Merck & Co., Inc. merck.com (opens in a new tab) 1,320 reports
4 GSK PLC gsk.com (opens in a new tab) 1,254 reports
5 Bristol-Myers Squibb bms.com (opens in a new tab) 627 reports
6 Johnson & Johnson jnj.com (opens in a new tab) 2,376 reports
7 AbbVie Inc. abbvie.com (opens in a new tab) 1,254 reports
8 Roche roche.com (opens in a new tab) 1,485 reports

Also active in HIV Drugs

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in HIV Drugs, from free public records
CompanyWhere public records show them
Aurobindo Pharma
Mylan N.V.
Macleods Pharmaceuticals
Cipla Inc.
Laurus
BioNTech
Hetero Laboratories
Hetero Laboratories Ltd Iii
bioLytical Laboratories
Frantz Viral Therapeutics, LLC
Jiangsu Aidea Pharmaceutical Group Co., Ltd.
Jecho Biopharmaceuticals Co., Ltd.

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Source: WHO Prequalification, Vaccines, tests and medicines on the WHO prequalified lists that match this market. Retrieved 13 Nov 2026.

Top trial sponsors in HIV Drugs

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. ViiV Healthcare 25 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Gilead Sciences, Inc. 14 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Merck & Co., Inc. 11 active trials on ClinicalTrials.gov (opens in a new tab)
  4. BioNTech 3 active trials on ClinicalTrials.gov (opens in a new tab)
  5. bioLytical Laboratories 2 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Frantz Viral Therapeutics, LLC 2 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Jiangsu Aidea Pharmaceutical Group Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Jecho Biopharmaceuticals Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

HIV Drugs reports by place

All 33 places for HIV Drugs

Get the full HIV Drugs report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.